Editing Narrow-spectrum antibiotic (section)

==Advantages==
* Narrow-spectrum antibiotic allow to kill or inhibit only those bacteria species that are unwanted (i.e. causing disease). As such, it leaves most of the beneficial bacteria unaffected, hence minimizing the collateral damage on the [[Human microbiome|microbiota]].<ref name="Blaser_2011">{{cite journal | vauthors = Blaser M | title = Antibiotic overuse: Stop the killing of beneficial bacteria | journal = Nature | volume = 476 | issue = 7361 | pages = 393–4 | date = August 2011 | pmid = 21866137 | doi = 10.1038/476393a | bibcode = 2011Natur.476..393B | s2cid = 205066874 | doi-access = free }}</ref><ref>{{cite web | first = Amanda B. | last = Keener
| name-list-style = vanc | date = 9 May 2016 |title=Narrow-Spectrum Antibiotic Could Spare the Microbiome|url=https://www.the-scientist.com/news-opinion/narrow-spectrum-antibiotic-could-spare-the-microbiome-33559|access-date=2020-06-07|website=The Scientist Magazine®|language=en}}</ref>
* Low propensity for [[Antimicrobial resistance|bacterial resistance]] development.<ref>{{cite journal | vauthors = Melander RJ, Zurawski DV, Melander C | title = Narrow-Spectrum Antibacterial Agents | journal = MedChemComm | volume = 9 | pages = 12–21 | date = 2018 | issue = 1 | pmid = 29527285 | pmc = 5839511 | doi = 10.1039/c7md00528h }}</ref>